Healthy.Capital

We are inspired by a vision for the future in which data, computing, networks, and other digital and deep technologies deliver meaningful outcomes and insight for improving health and the provision of care. We invest in both solutions intended for use in the diagnosis or cure of disease and solutions designed to help healthcare organizations - be them hospitals, biopharmas, insurers, etc. - be better at what they do. We see our sweet spot at seeding founders who are marrying in-depth understanding of the complex network of healthcare system participants with meaningful engineering innovation, advanced data science, and information technology-enabled products and services. We look for and invest in founders determined to effectively and efficiently serve these participants on the european continent, where we are based, and internationally.​ In our investment criteria and process, we are informed by a Stanford-born methodology of health technology innovation known as Biodesign. Since 2001, Biodesign has proven to de-risk the process of new venture creation by applying a need-driven and value-based approach to reinventing healthcare with the help of technology. To learn more about the methodology, head to The Student Guide to Biodesign, developed by a team of Stanford instructors and students who are passionate about education and making high-quality learning materials available and accessible to all.​ We invest in european companies as well as in selected non-european companies with ties to europe. Wherever they are, our goal is to help founders ready their companies to raise series A capital, and to access international markets. To learn more about our process, click here.

We partner with companies that create entirely new markets. For more than 25 years, and longer than almost any other investor in the country, our Principals have financed and helped build more successful healthcare industry "firsts" and companies that became market leaders. We invest on behalf of many of the largest healthcare organizations in the country, many of healthcare's most accomplished senior executives, and an outstanding group of global institutional investors. Our Principals have worked with strategic investors for longer than almost anyone in the industry. Collectively, Health Velocity Capital’s investors represent organizations that. INSURE MORE THAN 175M AMERICANS OPERATE >700 HOSPITALS PROVIDE PHARMACY & PBM SERVICES TO 75% OF THE NATION EMPLOY 5.0M AMERICANS GENERATE $2.1T IN REVENUE We leverage these relationships to help drive revenue and build teams In a highly process-driven and symbiotic manner, our Principals have used their networks to tangibly create equity value at more than 95% of the companies with which they have partnered. 10,000+ CONVERSATIONS WITH STRATEGIC INVESTORS 1000+ COMPANIES DISCUSSED $40B+ EQUITY VALUE CREATION 100+ EXECUTIVES PLACED 200+ COMMERCIAL RELATIONSHIPS FACILITATED We’re an investment firm that is driven by purpose, a clear mission, and an important set of core values Our mission is to generate outstanding financial returns while being the preferred innovation partner of entrepreneurs and investors working toward a more affordable, sustainable, consumer-friendly healthcare system.

Based on our thesis the convergence of healthcare and technology builds the basis for the next wave of market leaders across the full patient journey. We offer not only financial support, but also immediate access to the German healthcare ecosystem. Heal Capital is backed by leading private health insurances and deeply rooted across the German healthcare ecosystem.

InVitro Capital is a venture studio that creates, builds, and exits companies in the AI and B2B space. With a primary focus on Healthcare and SaaS, Invitro has developed a unique recipe to de-risk startup innovation and help aspiring exceptional entrepreneurs identify and capitalize on promising opportunities. At InVitro, we believe that the best startups are built by teams with deep domain expertise and a passion for solving real-world problems. That's why we invest in and partner with entrepreneurs who have a proven track record of success and a vision for the future. We provide our portfolio companies with the operational muscles and support they need to succeed, including: Seed funding. Access to our network of mentors and advisors. Expertise in tech, marketing, sales, and business development. Help with go-to-market strategy. We also have a unique approach to exits. Instead of waiting for a large tech company to come knocking, we actively work with our portfolio companies to develop and execute their own exit strategies. This allows us to maximize returns for our investors and give our entrepreneurs the freedom to pursue their next big idea

Established in 2023, KP Rx is a 100% founder-owned investment firm specialising in private and early-stage public healthcare investments in Australia and New Zealand. Founded by Hashan De Silva and backed by Karst Peak Capital, the firm targets high-potential biotech, medical devices, diagnostics, and health tech companies at a pivotal inflection point of value creation. Our Focus Creating a portfolio of Australia’s most promising healthcare companies. Our focus is on companies at or after Series A, specifically biotech companies at Phase 2 or medical device companies at or after regulatory clearance. Small-molecule Drugs Biological Products Cell & Gene Therapies Medical Devices Diagnostic Technologies AI for Healthcare Healthcare Software / SaaS Data and Analytics

Healthcare in India is a broken experience for most patients. Challenges of access, quality of care and non-holistic solutions exist across patient demographics At 2070 Health, we aim to strike at the heart of the problem by addressing the challenges that hinder innovation in this industry and solve for the massive white spaces We are India’s first Venture Studio building patient-centric healthcare companies from scratch by bringing together futuristic ideas, exceptional founders, and a powerful innovation platform Building a series of ventures from concept to scale Our proven 4-step process lets us replicate success across ventures. Through research-driven concepts and an expert-led approach, we’re able to build and scale sustainable companies STEP 1: Ideation & deep validation We discover disruptive opportunities through fundamental research and deep diligence. We kill 90% ideas with conviction through a structured research process, and introducing several stage gates before the idea sees the light of day ​ STEP 2: Team Building We set the business up for success by bringing in exceptional founders and early team. We are building India's largest talent universe with thousands of potential founders, to create a pipeline of rockstar business leaders STEP 3: Launch We expedite growth via our powerful Innovation Platform: technology stack, omnichannel GTM capabilities, marketing expertise, talent ecosystem, powerful partnerships, and capital​ STEP 4: Scale Up We leverage functional playbooks across Tech, Growth, Marketing, Finance, Legal & Regulatory, etc. to support growth, till the company reaches maturity​ Innovation. Impact. Healthcare.Respect: We will treat each other with respect. Every individual will be valued for their unique contributions and everyone will be treated with fairness, and compassion Honesty: We will be honest in our words and actions --- do right by others, have a backbone, and speak up Action: We will have an insatiable, no-nonsense drive for action and accountability. We will take prompt and decisive actions in the face of uncertainty or ambiguity Collaboration: We recognize that our vision of transforming healthcare is a monumental one, and cannot be achieved by individual efforts until we leverage the power of the team Positivity: We will stay focused, agile, and positive even in tough times. We will learn from failures, and will be relentless in our pursuit of excellence. Giving up is never an option Innovation: We will ideate & innovate with boldness & courage as we venture on ‘the road not taken’